Marina Komaroff, DrPH
Research and Development, Noven Pharmaceuticals, Inc., Jersey City, New Jersey
Original Research
Asenapine Transdermal System for Schizophrenia
December 15, 2020
Transdermal asenapine administration may address unmet needs in patients with schizophrenia, including improved adherence. This phase 3 study assessed efficacy and safety of HP-3070, an asenapine transdermal system (patch),...